MEDICATION ACCESS BARRIERS FOR ELEXACAFTOR/TEZACAFTOR/IVACAFTOR-ELIGIBLE PEOPLE WITH CYSTIC FIBROSIS

被引：0
|
作者：
Dieni, O. [1 ]
Ryan, L. [1 ]
Stocks, A. [1 ]
Erdo, J. [1 ]
机构：
[1] Cyst Fibrosis Fdn, Bethesda, MD USA
来源：
PEDIATRIC PULMONOLOGY | 2020年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
811
引用
收藏
页码：S359 / S359
页数：1
相关论文
共 50 条
  • [31] The impact of elexacaftor/tezacaftor/ivacaftor on fat-soluble vitamin levels in people with cystic fibrosis
    Hergenroeder, Georgene E.
    Faino, Anna
    Bridges, Gracia
    Bartlett, Lauren E.
    Cogen, Jonathan
    Green, Nicole
    Mcnamara, Sharon
    Nichols, David P.
    Ramos, Kathleen J.
    JOURNAL OF CYSTIC FIBROSIS, 2023, 22 (06) : 1048 - 1053
  • [32] Effect of elexacaftor/tezacaftor/ivacaftor on airway and systemic inflammation in cystic fibrosis
    Casey, Michelle
    Gabillard-Lefort, Claudie
    McElvaney, Oisin F.
    McElvaney, Oliver J.
    Carroll, Tomas
    Heeney, Ronan C.
    Gunaratnam, Cedric
    Reeves, Emer P.
    Murphy, Mark P.
    McElvaney, Noel G.
    THORAX, 2023, 78 (08) : 835 - 839
  • [33] Elexacaftor/tezacaftor/ivacaftor corrects monocyte microbicidal deficiency in cystic fibrosis
    Cavinato, Luca
    Luly, Francesco R.
    Pastore, Valentina
    Chiappetta, Daniele
    Sangiorgi, Gloria
    Ferrara, Eva
    Baiocchi, Pia
    Mandarello, Giuseppe
    Cimino, Giuseppe
    Del Porto, Paola
    Ascenzioni, Fiorentina
    EUROPEAN RESPIRATORY JOURNAL, 2023, 61 (04)
  • [34] Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Advanced Cystic Fibrosis Lung Disease
    Djavid, Amir Reza
    Thompson, Alison E.
    Irace, Alexandria L.
    Gusman, Elen
    Altman, Kimberly
    DiMango, Emily A.
    Keating, Claire L.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (11) : 1924 - 1927
  • [35] Elexacaftor-tezacaftor-ivacaftor overdose in an adolescent female with cystic fibrosis
    Lyman, Benjamin C.
    Seay, Jessica
    Contreary, Casey
    Savant, Adrienne P.
    Dell, Mary Lynn
    Hescock, George C.
    PEDIATRIC PULMONOLOGY, 2022, 57 (12) : 3174 - 3176
  • [36] Characterization of sleep in emerging adults with cystic fibrosis on elexacaftor/tezacaftor/ivacaftor
    Meltzer, Lisa J.
    Gross, Jane E.
    JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (01) : 132 - 136
  • [37] EFFECTS OF ELEXACAFTOR/ TEZACAFTOR/ IVACAFTOR ON MARKERS OF LIVER FIBROSIS IN ADULTS WITH CYSTIC FIBROSIS
    Portolese, Olivia
    Bilodeau, Marc
    Castel, Helene
    Willems, Bernard E.
    Huard, Genevieve
    Vincent, Catherine
    Lavoie, Annick
    Hercun, Julian
    HEPATOLOGY, 2023, 78 : S638 - S639
  • [38] Effects of elexacaftor/tezacaftor/ivacaftor on liver fibrosis markers in adults with cystic fibrosis
    Tewkesbury, Daniel H.
    Scott, Jennifer
    Barry, Peter J.
    Bright-Thomas, Rowland J.
    Hanley, Karen Piper
    Athwal, Varinder
    Jones, Andrew M.
    JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (02) : 349 - 353
  • [39] Elexacaftor/Tezacaftor/Ivacaftor Treatment Accessibility and Mental Health: Reducing Anxiety in People With Cystic Fibrosis
    Uzunoglu, Burcu
    Balci, Merve Selcuk
    Kalyoncu, Mine
    Karabulut, Seyda
    Cakar, Neval Metin
    Yildiz, Ceren Ayca
    Tastan, Gamze
    Kocaman, Damla
    Ergenekon, Almala Pinar
    Gokdemir, Yasemin
    Eralp, Ela Erdem
    Karakoc, Fazilet
    Karadag, Buelent
    PEDIATRIC PULMONOLOGY, 2025, 60 (03)
  • [40] Characteristics of individuals with cystic fibrosis in the United States ineligible for ivacaftor and elexacaftor/tezacaftor/ivacaftor
    Sanders, Don B.
    Mayer-Hamblett, Nicole
    Rosenfeld, Margaret
    Polinieni, Deepika
    Dasenbrook, Elliott
    Szczesniak, Rhonda
    Cromwell, Elizabeth A.
    JOURNAL OF CYSTIC FIBROSIS, 2025, 24 (02) : 255 - 262
12345